# FDA Inspection 1326078 - North Louisiana Tissue Bank - June 30, 2026

Source: https://www.keypedia.com/records/fda_inspections/north-louisiana-tissue-bank/f7b5c2f6-3553-4d64-b2e2-435a69146242
Source feed: FDA_Inspections

> FDA Inspection 1326078 for North Louisiana Tissue Bank on June 30, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326078
- Company Name: North Louisiana Tissue Bank
- Inspection Date: 2026-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1192838 - 2022-12-01](https://www.keypedia.com/records/fda_inspections/north-louisiana-tissue-bank/e86939b1-f335-48c2-a0f1-93d6566254da)
- [FDA Inspection 1192838 - 2022-12-01](https://www.keypedia.com/records/fda_inspections/north-louisiana-tissue-bank/a0f1123e-68a4-4582-aca3-8876ee34e9a1)
- [FDA Inspection 1152959 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/north-louisiana-tissue-bank/d2149d8b-d1ee-48fa-91d6-13a3183f7a62)

Company: https://www.keypedia.com/companies/north-louisiana-tissue-bank/661d9e31-71be-43ad-92eb-c8b5acdff21a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d